Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM5BP6BS2
The NM_000548.5(TSC2):āc.538C>Gā(p.Leu180Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L180P) has been classified as Pathogenic.
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Verdict is Likely_benign. Variant got -3 ACMG points.
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-2055459-T-C is described in Lovd as [Pathogenic].
BP6
Variant 16-2055458-C-G is Benign according to our data. Variant chr16-2055458-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 49846.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=5, not_provided=1, Benign=1}. Variant chr16-2055458-C-G is described in Lovd as [Benign]. Variant chr16-2055458-C-G is described in Lovd as [Likely_benign].
Likely benign, criteria provided, single submitter
clinical testing
All of Us Research Program, National Institutes of Health
Sep 23, 2024
- -
Uncertain significance, criteria provided, single submitter
clinical testing
Illumina Laboratory Services, Illumina
Jan 13, 2018
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Seizure Uncertain:1
Uncertain significance, no assertion criteria provided
clinical testing
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital
Dec 19, 2016
- -
not specified Benign:1
Likely benign, criteria provided, single submitter
clinical testing
GeneDx
Feb 19, 2018
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter
clinical testing
Ambry Genetics
Aug 11, 2021
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -